Crescent Capital locks in $1b whilst CEFC cuts a cheque
SYDNEY: Australian Clinical Labs’ eccentric bid for bigger rival Healius has not been the only
SYDNEY: Australian Clinical Labs’ eccentric bid for bigger rival Healius has not been the only